                         SEQUENCE LISTING

<110>  Universit degli Studi di Milano
       Universit degli Studi di Roma "Tor Vergata"
       Universit Politecnica delle Marche
 
<120>  JNK3 inhibitory peptides

<130>  DR/20095/PCT

<160>  5     

<170>  PatentIn version 3.5

<210>  SEQ ID NO: 1
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed peptide based on size and structure to act in the 
       interaction among beta-arrestin-2 and JNK3

<400>  1

Ser Asp Arg Ser Leu His Leu Glu Ala Asn Glu Lys Gly Glu Asn Val 
1               5                   10                  15      


Asn Val His Val Thr Lys Thr Arg Ala Asp Lys Ser Lys Ile Lys Val 
            20                  25                  30          


Ser Val Arg Gln Tyr Ala Asp Ile Asn Glu Lys Gly Glu Ala Gln Tyr 
        35                  40                  45              


Lys Cys Pro Val Ala Gln Leu Glu 
    50                  55      


<210>  SEQ ID NO:2
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed peptide based on size and structure to act in the 
       interaction among beta-arrestin-2 and JNK3

<400>  2

Ser Asp Arg Ser Leu His Leu Glu Ala Glu Lys Gly Asn Val Asn Val 
1               5                   10                  15      


His Val Thr Lys Thr Glu Lys Gly Lys Ile Lys Val Ser Val Arg Gln 
            20                  25                  30          


Tyr Ala Asp Ile Glu Lys Gly Ala Gln Tyr Lys Cys Pro Val Ala Gln 
        35                  40                  45              


Leu Glu 
    50  


<210>  SEQ ID NO:3
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed peptide based on size and structure to act in the 
       interaction among beta-arrestin-2 and JNK3

<400>  3

Ser Asp Arg Ser Leu His Leu Glu Ala Glu Lys Gly Asn Val Asn Val 
1               5                   10                  15      


His Val Thr Lys Thr Ala Asp Lys Lys Ile Lys Val Ser Val Arg Gln 
            20                  25                  30          


Tyr Ala Asp Ile Glu Lys Gly Ala Gln Tyr Lys Cys Pro Val Ala Gln 
        35                  40                  45              


Leu Glu 
    50  


<210>  SEQ ID NO: 4
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Designed peptide based on size and structure to act in the 
       interaction among beta-arrestin-2 and JNK3

<400>  4

Ser Asp Arg Ser Leu His Leu Glu Ala Asn Glu Lys Gly Glu Asn Val 
1               5                   10                  15      


Asn Val His Val Thr Lys Thr Asn Glu Lys Gly Glu Lys Ile Lys Val 
            20                  25                  30          


Ser Val Arg Gln Tyr Ala Asp Ile Asn Glu Lys Gly Glu Ala Gln Tyr 
        35                  40                  45              


Lys Cys Pro Val Ala Gln Leu Glu 
    50                  55      


<210>  SEQ ID NO: 5
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protein TAT

<400>  5

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


